These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20823993)

  • 1. Thrombin Generation Capacity of Methylene Blue-Treated Plasma Prepared by the Theraflex MB Plasma System.
    Gravemann U; Kusch M; Koenig H; Mohr H; Mueller TH
    Transfus Med Hemother; 2009; 36(2):122-127. PubMed ID: 20823993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombin generation capacity is impaired in methylene-blue treated plasma compared to normal levels in single-donor fresh-frozen plasma, a licensed solvent/detergent-treated plasma (Octaplas) and a development product (Uniplas).
    Pock K; Heger A; Janisch S; Svae TE; Römisch J
    Transfus Apher Sci; 2007 Dec; 37(3):223-31. PubMed ID: 18006380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen.
    Osselaer JC; Debry C; Goffaux M; Pineau J; Calomme G; Dubuc E; Chatelain B; Vandendaele MC; Hsu J; Rheinschmidt M; Lin L
    Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma temperature during methylene blue/light treatment influences virus inactivation capacity and product quality.
    Gravemann U; Handke W; Sumian C; Alvarez I; Reichenberg S; Müller TH; Seltsam A
    Vox Sang; 2018 May; 113(4):368-377. PubMed ID: 29484670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of plasma after methylene blue and white light treatment in four Chinese blood centers.
    Chunhui Y; Guohui B; Hong Y; Xiaopu X; Zherong B; Mingyuan W; Xinsheng Z; Juanjuan W; Changqing L; Wuping L
    Transfus Apher Sci; 2013 Dec; 49(3):631-9. PubMed ID: 23928128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma.
    Zeiler T; Riess H; Wittmann G; Hintz G; Zimmermann R; Müller C; Heuft HG; Huhn D
    Transfusion; 1994 Aug; 34(8):685-9. PubMed ID: 8073485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filtration of methylene blue-photooxidized plasma: influence on coagulation and cellular contamination.
    Riggert J; Humpe A; Legler TJ; Wolf C; Simson G; Köhler M
    Transfusion; 2001 Jan; 41(1):82-6. PubMed ID: 11161250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paired comparison of methylene blue- and amotosalen-treated plasma and cryoprecipitate.
    Backholer L; Wiltshire M; Proffitt S; Cookson P; Cardigan R
    Vox Sang; 2016 May; 110(4):352-61. PubMed ID: 26757252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenge study of the pathogen reduction capacity of the THERAFLEX MB-Plasma technology.
    Reichenberg S; Gravemann U; Sumian C; Seltsam A
    Vox Sang; 2015 Aug; 109(2):129-37. PubMed ID: 25899343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light.
    Faddy HM; Fryk JJ; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC
    Transfusion; 2019 Jul; 59(7):2223-2227. PubMed ID: 31050821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Initial experiences with methylene blue virus inactivated fresh frozen plasma: results of a clinical and in vitro study].
    Wieding JU; Neumeyer H
    Infusionsther Transfusionsmed; 1992 Apr; 19(2):84-90. PubMed ID: 1623325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemovigilance data on the use of methylene blue virally inactivated fresh frozen plasma with the Theraflex MB-Plasma System in comparison to quarantine plasma: 11 years' experience.
    Politis C; Kavallierou L; Hantziara S; Parara M; Zervou E; Katsarou O; Hatzitaki M; Fountouli P; Gioka A; Tzioura K; Koumarianos S; Asariotou M; Richardson C
    Transfus Med; 2014 Oct; 24(5):316-20. PubMed ID: 25262924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light.
    Fryk JJ; Marks DC; Hobson-Peters J; Watterson D; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Faddy HM
    Transfusion; 2017 Nov; 57(11):2677-2682. PubMed ID: 28718518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activity and concentration determinations of coagulation factors in conventional and virus-inactivated coagulation-active plasma].
    Lutze G; Hartung KJ
    Beitr Infusionsther Transfusionsmed; 1994; 32():415-8. PubMed ID: 9480135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants.
    Aznar JA; Bonanad S; Montoro JM; Hurtado C; Cid AR; Soler MA; De Miguel A
    Vox Sang; 2000; 79(3):156-60. PubMed ID: 11111234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.
    Cardigan R; Philpot K; Cookson P; Luddington R
    Transfusion; 2009 Apr; 49(4):696-703. PubMed ID: 19170989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of Japanese encephalitis virus in plasma by methylene blue combined with visible light and in platelet concentrates by ultraviolet C light.
    Rustanti L; Hobson-Peters J; Colmant AMG; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC; Faddy HM
    Transfusion; 2020 Nov; 60(11):2655-2660. PubMed ID: 32830340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction.
    Seghatchian J; Struff WG; Reichenberg S
    Transfus Med Hemother; 2011; 38(1):55-64. PubMed ID: 21779206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in functional activities of plasma fibrinogen after treatment with methylene blue and red light.
    Suontaka AM; Blombäck M; Chapman J
    Transfusion; 2003 May; 43(5):568-75. PubMed ID: 12702176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo haemostatic capacity of plasma upon thawing and beyond: a comparison between fresh frozen plasma (FFP) and frozen plasma prepared from whole blood stored at room temperature up to 24 hours postcollection (RTFP24).
    Ang AL; Wong WH; Tan J; Ng HJ; Tan CW; Kuperan P; Lam S; Tan HH; Chua SS
    Vox Sang; 2019 Apr; 114(3):198-206. PubMed ID: 30734312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.